Impact of PLK-1 Silencing on Endothelial Cells and Cancer Cells of Diverse Histological Origin

E-ISSN： 1875-5631|13|3|189-201

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.13, Iss.3, 2013-06, pp. : 189-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Silencing of Tumor Necrosis Factor Receptor-1 in Human Lung Microvascular Endothelial Cells Using Particle Platforms for siRNA Delivery

Current Drug Targets, Vol. 16, Iss. 13, 2015-12 ,pp. : 1531-1539

Bentham Science Publishers

Access to resources Recommend Favorite

Retrovirus Silencing and Vector Design: Relevance to Normal and Cancer Stem Cells?

Current Gene Therapy, Vol. 5, Iss. 4, 2005-08 ,pp. : 367-373

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Cells in Inflammation and Angiogenesis

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 319-323

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Progenitor Cells in Prehypertension

Current Pharmaceutical Design, Vol. 17, Iss. 28, 2011-09 ,pp. : 3002-3019

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclosporin A induces prepro endothelin-1 gene transcription in human endothelial cells

By Marsen T.A. Weber F. Egink G. Suckau G. Baldamus C.A.

European Journal of Pharmacology, Vol. 379, Iss. 1, 1999-08 ,pp. : 97-106

Elsevier

Access to resources Recommend Favorite